ArticleInvestigational new drugs2013

A phase I study of sorafenib and vorinostat in patients with advanced solid tumors with expanded cohorts in renal cell carcinoma and non-small cell lung cancer.

A Dasari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.